Current Surgical is developing a new focused ultrasound technology stack that gives surgeons millimeter-level control for precision treatment of malignant tissue. The surgical platform combines real-time imaging with precise energy delivery, unlocking applications far beyond the initial oncology focus. The company is starting with solid tumor ablation, and can rapidly expand into cardiac arrhythmias, chronic pain, hypertension, epilepsy, and other neural interventions.